Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
PRODUCT BULLETIN AcroMetrix® quality control products Independent QC materials for infectious disease testing AcroMetrix quality control products ® As molecular diagnostics expands in the clinical setting, laboratories face the challenges of implementing new tests and finding dependable, convenient, and affordable quality control materials to monitor assay performance. Prior to reporting patient results, validation or verification is required to establish or verify the performance characteristics of a new molecular diagnostic assay. For each test system, the laboratory is responsible for having control procedures that monitor the accuracy and precision of the complete analytical process. Life Technologies has innovative standards, external run controls, and validation and verification materials (now offered under the AcroMetrix® brand name) that offer an effective solution to some of the challenges that you face. The AcroMetrix® portfolio provides molecular quality control products that aid laboratories in meeting quality and regulatory requirements. Additionally, these products support the goal of standardization in molecular testing by establishing traceability of results and by providing commutable material that can help ensure consistent, accurate, and meaningful test results. Using AcroMetrix® panels and controls enables a lab to: • Validate and verify new assays • Monitor assay and instrument performance over time • Troubleshoot procedural errors • Train laboratory personnel to accurately perform assays AcroMetrix® Infectious Disease Panels AcroMetrix® Infectious Disease Panels for HIV-1, HBV, and HCV nucleic acid testing (NAT) allow laboratories to readily verify assays with confidence and are used to establish or verify performance specifications for accuracy, precision, reportable range, analytical sensitivity, and analytical specificity (Figures 1–3). These valuable tools can also be used for laboratory personnel proficiency testing. Inhibition panel assists with assay evaluation The AcroMetrix® Inhibition Panel is a seven-member panel that provides quantified amounts of commonly recognized assay inhibitors, including heparin, lipids, bilirubin, and hemolyzed plasma. This panel can be used for assay validation, instrument evaluation, commercial and in-house assay characterization, and troubleshooting. Diluting the panel members allows Observed titer (log IU/mL) Roche Lab 2 y = 0.9738x - 0.2217 R2 = 0.9969 Roche Lab 3 y = 1.1107x - 0.6649 R2 = 0.9798 Roche Lab 4 y = 0.9459x + 0.3511 R2 = 0.9984 Abbott Lab 1 y = 0.9735x + 0.077 R2 = 0.9996 Roche COBAS® AmpliPrep/COBAS® TaqMan® HCV Test (IVD) Roche COBAS® AmpliPrep/COBAS® TaqMan® HCV Test (RUO/ASR) Abbott RealTime™ HCV Viral Load Test 8 7 6 5 4 3 2 1 0 0 1 2 3 4 5 6 7 8 Expected titer (log IU/mL) Figure 1. AcroMetrix® HCV-s Panel: A Multi-Center Evaluation. The AcroMetrix® HCV-s Panel is accurately and precisely detected by a variety of sample preparation and nucleic acid amplification systems, including the COBAS® TaqMan® HCV systems (Roche) and the RealTime™ HCV Viral Load Test (Abbott) on the Abbott m2000™ System. The panel is highly linear with members from 100 IU/mL up to 2.5E7 IU/mL. (Note: Data were obtained from customer site evaluations. Performance characteristics should be established by each laboratory.) 9 Observed titer (log IU/mL) Verify or validate larger reportable ranges with ease AcroMetrix® Infectious Disease Panels provide laboratories with the largest ranges of panel concentrations available for molecular testing. Based on the revolutionary SynTura™ technology, the AcroMetrix® HCV-s Panel consists of panel members with concentrations from 1E2 IU/mL to 2.5E7 IU/mL, enabling laboratories to verify or validate a larger reportable range. Also, the AcroMetrix® HBV Panel 1.2 mL has the largest dynamic range of concentrations available for quantitative HBV DNA assays, from 50 IU/mL to 5E7 IU/mL. 9 Observed titer = Expected titer 8 Roche COBAS® TaqMan® HBV Test 7 y = 1.0093x - 0.0465 R2 = 0.9974 6 5 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 Expected titer (log IU/mL) Figure 2. Evaluation of the AcroMetrix® HBV Panel 1.2 mL. The AcroMetrix® HBV Panel produces linear results using the Roche COBAS® TaqMan® HBV Test kit (Roche) with the High Pure System Viral Nucleic Acid Kit (Roche). An intercept close to zero shows that minimal inhibitors are present. (Note: Data were obtained from customer site evaluations. Performance characteristics should be established by each laboratory.) 7 Observed titer (log copies/mL) Excellent traceability for accurate reporting AcroMetrix® HIV-1, HBV, and HCV Panel members are traceable to WHO International Standards, helping to ensure more accurate reportable results and allowing for interlaboratory comparisons. Additionally, the panels contain whole virus in human plasma–based matrices and behave similarly to patient samples. Roche Lab 1 y = 0.9891x + 0.3644 R2 = 0.9991 6 Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Test, v1.0 y = 1.03x - 0.026; R2 = 0.9995 5 Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Test, v2.0 y = 1.0342x - 0.0522; R2 = 0.996 4 Abbott RealTime™ HIV-1 Viral Load Test y = 1.02x - 0.103; R2 = 0.9991 3 2 1 0 0 1 2 3 4 5 6 7 Expected titer (log copies/mL) Figure 3. AcroMetrix® HIV-1 Panel copies/mL. The AcroMetrix® HIV-1 Panel is highly linear with members from 100 copies/mL to 5E6 copies/mL and will be accurately and precisely detected by both the COBAS® AmpliPrep/TaqMan® HIV-1 system (Roche) and the RealTime™ HIV-1 Viral Load Test (Abbott) on the Abbott m2000™ System. (Note: Data were obtained from customer site evaluations. Performance characteristics should be established by each laboratory.) The AcroMetrix® EV (enterovirus) Low Control contains inactivated, encapsidated viral particles, allowing for verification of effective viral RNA extraction and purification as well as amplification and detection. Both positive and negative EV controls are diluted in a proprietary synthetic matrix designed to mimic naturally occurring human cerebrospinal fluid (CSF) specimens. Accurately monitor assay performance over time In accordance with ISO 17511, AcroMetrix® HIV-1, HBV, and HCV Controls are calibrated against WHO International Standards and the AcroMetrix® EV Low Control is calibrated against a highly stable in-house enterovirus standard. This traceability to a higher-order standard helps ensure excellent reproducibility from lot to lot of control, assisting laboratories in accurately monitoring assay performance over time and across reagent lot changes. AcroMetrix® HCV High Control Negative Control Hemolyzed Low Plasma Hemolyzed Mid Plasma B Hemolyzed High Plasma Heparin Triglycerides Bilirubin C 38 PCR occurs as expected PCR occurs with some inhibition 36 Ct AcroMetrix® Infectious Disease Controls Controls that mimic your patient samples AcroMetrix® HIV-1, HBV, and HCV Controls are the only true full-process HIV-1, HBV, and HCV quality controls commercially available. Made from whole, unaltered virus in plasma-based matrices, these controls simulate patient samples from extraction through amplification and detection. A Amount of DNA/RNA (copies/mL) for the testing of inhibitory limits such that the level of inhibition becomes apparent (Figure 4). 34 32 PCR reaction completely inhibited 30 EDTA Haemolyzed low Haemolyzed mid Haemolyzed high Heparinized Lipemic Icteric Figure 4. The AcroMetrix® Inhibition Panel can be used to show the effects of common inhibitors on PCR. (A) After spiking AcroMetrix® Inhibition Panel members with a known concentration of viral sample, panel members can be treated just like patient samples. (B) PCR results can show the effects of inhibitors on PCR. (C) A typical example of the inhibitory effects on Ct values. AcroMetrix® HIV-1 High Control In acute HIV-1 infections, the levels of RNA in plasma can range from 1.7E5 to 1.7E7 IU/mL. Because assay reagents can vary from lot to lot, it is critical to perform routine quality control between these levels. The AcroMetrix® HIV-1 High Control has the highest HIV-1 titer available and can help your laboratory monitor reagent lot variation and detect systematic errors within the upper end of your assay’s dynamic range. This control contains the noninfectious 8E5 HIV-1 strain to provide maximum safety in your laboratory, decreasing exposure to potentially dangerous high-titer infectious HIV material and ensuring a safe and productive work environment. It also provides results traceable to the WHO 2nd International Standard for HIV-1 RNA in accordance with ISO 17511. Online tool for assay validation Define your study parameters using the EZValidation™ Online Tool Instead of spending several weeks to design and perform a verification or validation of your quantitative molecular assay, you can use the EZValidation™ tool in combination with AcroMetrix® panels and controls to speed up your assay validation. You choose which standard guidelines to follow and the EZValidation™ tool calculates the number of reactions and quality control materials required, and applies statistical analysis to your data to generate a final report that supports user validation and verification of molecular tests. Ordering information Target HIV Product Fill Package Regulatory volume size designation Cat. No. AcroMetrix® HIV-1 Panel IU/mL (0, 1E2, 1E3, 1E4, 1E5, 1E6, 1E7 IU/mL) 1.2 mL 7 vials RUO 942013 AcroMetrix HIV-1 Panel copies/mL (0, 1E2, 5E2, 5E3, 5E4, 5E5, 5E6 copies/mL) 1.2 mL 7 vials RUO 950470 AcroMetrix® HIV-1 Low Control 1.2 mL 5 vials IVD, CE-IVD 964001 AcroMetrix HIV-1 Mid Control 1.2 mL 5 vials IVD, CE-IVD 964002 AcroMetrix® HIV-1 High Control 1.2 mL 5 vials RUO 960403 AcroMetrix HIV-1 High Control* 1.2 mL 5 vials CE-IVD 964003 AcroMetrix Genotyping HIV RT/PR Mutant Control 0.5 mL 5 vials RUO 951502 AcroMetrix® HCV Panel (0, 5E1, 5E2, 5E3, 5E4, 5E5, 5E6 IU/mL) 0.5 mL 7 vials RUO 942011 AcroMetrix HCV-s Panel (1E2, 5E2, 5E3, 5E4, 5E5, 5E6, 2.5E7 IU/mL) 1.2 mL 7 vials RUO 950350 AcroMetrix HCV Genotyping Panel (Genotypes 1, 2, 3 & 4) 0.5 mL 4 vials RUO 942000 AcroMetrix® HCV Low Control 1.2 mL 5 vials IVD, CE-IVD 963001 AcroMetrix HCV Mid Control 1.2 mL 5 vials IVD, CE-IVD 963002 AcroMetrix® HCV High Control 1.2 mL 5 vials RUO 960203 AcroMetrix HCV High Control* 1.2 mL 5 vials CE-IVD 963003 AcroMetrix HBV Panel 0.5 mL (0, 2E2, 2E3, 2E4, 2E5, 2E6, 2E7 IU/mL) 0.5 mL 7 vials RUO 942012 AcroMetrix® HBV Panel 1.2 mL (5E1, 5E2, 5E3, 5E4, 5E5, 5E6, 5E7 IU/mL) 1.2 mL 7 vials RUO 950150 AcroMetrix HBV Low Control 1.0 mL 5 vials IVD, CE-IVD 965001 AcroMetrix HBV Mid Control 1.0 mL 5 vials IVD, CE-IVD 965002 AcroMetrix® HBV High Control 1.0 mL 5 vials RUO 960603 AcroMetrix HBV High Control* 1.0 mL 5 vials CE-IVD 965003 AcroMetrix® EV Negative Control 0.3 mL 5 vials RUO 950499 AcroMetrix EV Negative Control* 0.3 mL 5 vials CE-IVD 960499 AcroMetrix EV Low Control 0.3 mL 5 vials RUO 950500 AcroMetrix® EV Low Control* 0.3 mL 5 vials CE-IVD 960501 Negative AcroMetrix Negative Control* 1.0 mL 5 vials IVD, CE-IVD 962000A Inhibitors AcroMetrix Inhibition Panel (EDTA plasma; hemolyzed low, mid, high; 1.0 mL 7 vials RUO 956400 AcroMetrix® EDTA Plasma Dilution Matrix 45 mL 45 mL 1 bottle RUO S2284 AcroMetrix Ultra Serum Dilution Matrix 50 mL 1 bottle RUO S2285 AcroMetrix Citrate Plasma Dilution Matrix 50 mL 50 mL 1 bottle GPR 941050 AcroMetrix® Citrate Plasma Dilution Matrix 100 mL 100 mL 1 bottle GPR 941100 ® ® ® ® HCV ® ® ® ® HBV ® ® ® ® EV ® ® ® ® heparinized plasma; lipemic plasma; icteric plasma) Diluent ® ® Software EZValidation Online Tool (Introductory Promo—Single Study) 990500 EZValidation Online Tool (12 Month Subscription) 990501 EZValidation™ Online Tool (Single Study Use) 990506 ™ ™ * Not available in the U.S. To learn more about AcroMetrix® infectious disease products, go to acrometrix.com For Research Use Only. Not intended for any animal or human therapeutic or diagnostic use. © 2011 Life Technologies Corporation. All rights reserved. The trademarks mentioned herein are the property of Life Technologies Corporation or their respective owners. COBAS® is a registered trademark of Roche Diagnostics Operations, Inc. TaqMan® is a registered trademark of Roche Molecular Systems, Inc. Printed in the USA. CO23266 1011 Headquarters 5791 Van Allen Way | Carlsbad, CA 92008 USA | Phone +1.760.603.7200 | Toll Free in the USA 800.955.6288 www.lifetechnologies.com